The members of the European Parliament Intergroup on Cancer and Rare Diseases issued a clear warning: without adequate funding for health, the significant progress made so far is at risk, as is the well-being of millions of citizens living with cancer or rare conditions, including children.
Read more
Cancer remains one of the European Union’s most pressing public health challenges.
Every year, 2.7 million people are diagnosed with it, 1.3 million dies from it, and €49 billion in productivity is lost to it. Annual healthcare spending on cancer care and cancer control has now reached €93 billion in the 27 countries combined.
Read moreCancer control has improved impressively across Europe. But the specific needs of women are too often absent in European health policies, creating gaps that directly and negatively affect outcomes.
Read moreWarsaw, 24 November 2025 – The European Parliamentary Forum for Sexual and Reproductive Rights (EPF) together with the Institute for Patients‘ Rights and Health Education in Poland (IPPEZ) and the European Cancer Organisation (ECO) have launched the new edition of the HPV Prevention Policy Atlas 2025 at the Polish Senate during the event “HPV prevention in Poland and Europe”.
Read more
Brussels, 20 November – Each year brings with it 58,000 new cases of cervical cancer in Europe and 27,000 deaths from the disease – all the result of the human papillomavirus (HPV).
It does not have to be this way.
Read moreAn estimated 31% of men and 25% of women in the EU will receive a cancer diagnosis before the age of 75. Quality screening programmes are essential to improve treatment outcomes and save lives.
Throughout 2024-2025, the European Cancer Organisation (ECO) worked alongside leading cancer experts and partner organisations to assess the current state of cancer screening across Europe.
Read moreBrussels, 18 November – An estimated 31% of men and 25% of women in the EU will receive a cancer diagnosis by age 75. Technological advances in cancer screening approaches offer new opportunities for early detection, but a new analysis shows that too many Europeans are not benefiting from well organised and accessible screening programmes.
Read more
The European Cancer Organisation’s Research Policy Network, chaired by Professor Christine Chomienne, has published a new Green Paper on EU investment in cancer research.
Read moreA new report from the European Cancer Organisation (ECO) and its HPV and Hep B Action Network highlights persistent inequalities in cervical cancer screening and HPV testing across Europe. It calls for stronger implementation of EU recommendations, greater coordination among European countries, and more cohesion in vaccination and screening programmes.
Read more